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Abstract
Background: Antimicrobial resistance in Streptococcus pneumoniae has compromised the effectiveness
of therapy for pneumococcal diseases and asymptomatic nasopharyngeal carriers play an important
role in transmission of resistant strains.
Method: Eighty-eight volunteer students attending 2 secondary schools in Jos, Nigeria were involved in
this study to determine the antimicrobial resistant profile of Streptococcus pneumoniae isolated from
the nasopharynx. The study population consisted of males and females between the ages of 15 – 25
years. Nasopharyngeal swab samples were analyzed for the presence of S. pneumoniae using standard
bacteriological methods.
The isolates were subjected to antimicrobial susceptibility testing using the disc diffusion method.
Results: S. pneumoniae was isolated from 37(42.04%) of the 88 samples. Isolates showed the highest
resistance of 12 (32.43%) to erythromycin and lowest resistance of 4(10.81%) to ciprofloxacin. The
resistance profiles for the 26(70.27%) penicillin-sensitive and 11(29.72%) penicillin-resistant isolates
were similar. Both exhibited varying degrees of resistance to several groups of antimicrobials. However,
isolates found to be resistant to penicillin showed a higher degree of resistance to other antimicrobial
agents.
Conclusion: This study has shown that some secondary school students are carriers of multiple
antibiotic-resistant S. pneumoniae.
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Résumé
Fond: Résistance antimicrobienne dedans Streptocoque pneumoniae a compromis l'efficacité de la
thérapie pour les maladies pneumococcal et les porteurs nasopharyngaux asymptomatiques pour jouer
un rôle important par transmission des contraintes résistantes.
Méthode: Des étudiants volontaires d'Eighty-eight allant à 2 écoles secondaires en Jos, Nigéria ont été
impliqués dans cette étude pour déterminer le profil résistant antimicrobien de Streptocoque
pneumoniae d'isolement dans le nasopharynx. La population d'étude s'est composée des mâles et des
femelles entre les âges de 15 - 25 ans. Des échantillons nasopharyngaux de tige ont été analysés la
présence de S. pneumoniae employer des méthodes bactériologiques standard.
Les isolats ont été soumis à la susceptibilité antimicrobienne examinant en utilisant la méthode de
diffusion de disque.
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Résultats: S. pneumoniae a été isolé dans 37 (42.04%) des 88 échantillons. Les isolats ont montré la
résistance la plus élevée de 12 (32.43%) à l'érythromycine et la plus basse résistance de 4 (10.81%) au
ciprofloxacin. Les profils de résistance pour les 26 (70.27%) pénicilline-sensibles et 11 (29.72%) isolats
résistants à la pénicilline étaient semblables. Tous les deux ont montré des degrés variables de
résistance à plusieurs groupes d'antimicrobiens. Cependant, les isolats avérés résistants à la pénicilline
ont montré un degré plus élevé de résistance à d'autres agents antimicrobiens.
Conclusion: Cette étude a prouvé que quelques étudiants d'école secondaire sont des porteurs de
résistant aux antibiotiques multiple S. pneumoniae.
Mots clés: Antimicrobien, résistant, Streptocoque pneumoniae
Streptococcus pneumoniae is the etiologic agent
of many diseases. The spectrum of infections caused
by this bacterium ranges from otitis media and
bacteremia to pneumonia and meningitis.
1
The
human nasopharynx is the primary reservoir for S.
pneumoniae and the main source of person to person
transmission.
2
Strains of S. pneumoniae were usually considered
to be sensitive to penicillins before the 1960s and
routine antibiotic susceptibility testing were not
performed in hospitals.
3
The first clinically significant
isolate not susceptible to penicillin was reported in
1967 from Australia.
4
Since then penicillin-resistant S.




resistant strains have also been reported.
3, 7
S. pneumoniae is a leading cause of morbidity and
mortality especially in children, the elderly and the
immunocompromised, therefore its antimicrobial
resistance is of major concern.
8
Since the
nasopharynx is the primary source of pneumococci
the antimicrobial resistance profile of strains isolated
from there can be used to predict antimicrobial
resistance that may arise in clinically significant
isolates. Therefore, it has been used to assess




study was undertaken to determine the antimicrobial
resistant pattern of S. pneumoniae isolated from the




The study population consisted of 88 secondary
school students between 15 and 25 years. All
participants were apparently healthy without
respiratory tract infections and were currently not
using antibiotics at the time of sample collection.
Informed consent was obtained form each student
who participated in the study.
Specimen collection
Nasopharyngeal swab specimens were collected
using a sterile disposable wooden tongue depressor
to depress the tongue. A sterile cotton swab stick
was placed 1 to 1.5 in. into the nasopharynx. The
specimens were collected by a single investigator. All
specimens collected were then transported
immediately to the laboratory for analysis. The
specimens were processed within 1 to 3 hours after
collection.
Processing of specimens
Swab specimens were inoculated on tryptic soy
agar plates containing 5% sheep blood and incubated
at 37°C in 5 – 10% CO
2
(Candle extinction jar) for 24-
48hours. The isolates were identified according to
guidelines given by Duguid and Ross
10
which included
Gram stain, catalase test, optochin sensitivity test
and bile solubility test.
Susceptibility of isolates to antibiotics was
determined on Mueller-Hinton agar plates containing
5% sheep blood using the Kirby-Bauer disc diffusion
technique.
11
Susceptibility tests were performed
from a bacterial inoculum whose turbidity was
equivalent to that of a McFarland standard of 0.5.
The inoculum was produced from a pure culture of
the isolate to be tested. Staphylococcus aureus NCTC
No. 6571 and Escherichia coli NCTC No. 10418 were
used as controls.
The inocula were spread over the surface of the
agar plates and the antibiotic (Antec Diagnostics, UK)
discs were placed on the plates and incubated at
37°C in 5 – 10% CO
2
overnight. The diameter of the
zone of inhibition for each test antibiotic was
measured and sensitivity or resistance estimated by
comparing with zone-diameter interpretive standard
according to that recommended by the National
Committee for Clinical Laboratory Standards
(NCCLS).
12




tested were ciprofloxacin (10mcg), chloramphenicol
(10mcg), gentamicin (30mcg), tetracycline (10mcg),
erythromycin (10mcg), and ampicillin (10mcg).
Results
A total of 88 nasopharyngeal swab specimens
were collected and analyzed in this study. Results
indicate that Streptococcus pneumoniae was isolated
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from 37(42.04%) of the samples. Eleven (29.72%) of
S. pneumoniae isolated were found to be resistant to
penicillin and 26 (70.27%) sensitive.
Twelve (32.43%) of the isolates were resistant to
erythromycin, 11(29.72%) to oxacillin and ampicillin
10(27.02%) to tetracycline, 8(21.62%) to gentamicin
and chloramphenicol and 4(10.81%) were also
resistant to ciprofloxacin (Table 1).
The invitro antimicrobial resistant pattern for the
penicillin-resistant S. pneumoniae strains is as
follows; 6(54.54%) of the isolates were resistant to
ampicillin, 4(36.36%) to erythromycin, 3(27.27%) to
tetracycline and chloramphenicol, 2(18.18%) to
gentamicin and 1(9.09%) to ciprofloxacin (Table 2).
In Table 3 the invitro antimicrobial resistant
profile for the penicillin-sensitive S. pneumoniae
isolates is shown. Eight (30.77%) were resistant to
erythromycin and 7(26.92%) to tetracycline.
Table 1. Invitro antimicrobial resistant profile of




















Table 2. Invitro antimicrobial resistant profile of
11 penicillin-resistant S. pneumoniae strains

















Table 3. Invitro antimicrobial resistant profile of
26 penicillin sensitive S. pneumoniae strains


















The present study showed a 29.72% prevalence
rate for penicillin resistant Streptococcus
pneumoniae. This is similar to the 25% reported for 7
United States regions
13
but lower than the 41%
reported from Taiwan
14
and 42.9% from Ekpoma,
Nigeria.
3
Several factors have been reported to be
related to carriage and transmission of penicillin
resistant. S. pneumoniae however, the most
important factor is probably recent antibiotic use.
Other risk factors for resistant pneumococcal
carriage include young age, attendance at day care
centers and Human immunodeficiency virus (HIV)
infections in some populations.
15,16
Resistance to antibiotics of at least 3 different
groups has been defined as multiple drug
resistance.
17
Even though the rate of multiple
antibiotic resistance was not very high in this study
when compared with those in some other countries,
at least 21% of our isolates showed multiple drug
resistance. The relatively high frequency of resistance
of our isolates to penicillin and other antibiotics limits
the choice of antimicrobials that can be used for the
treatment of pneumococcal infections.
The antimicrobial susceptibility profiles for both
penicillin – sensitive and resistant strains of S.
pneumoniae were similar. Both exhibited varying
degrees of resistance to several groups of
antimicrobials. However, isolates found to be
resistant to penicillin showed a higher degree of
resistance to other antimicrobial agents. This agrees
with reported findings that pneumococcal isolates
resistant to penicillin are likely more resistant to




among pneumococci is mediated by changes in
penicillin – binding proteins which is found on the
surface of the bacteria and not by beta-lactamases.
18




however rates of resistance depend on many
variables.
18
For both penicillin – sensitive and
resistant isolates, the highest resistance rates were
recorded for erythromycin and the lowest for
ciprofloxacin. These rates are however lower than
those reported for the Ekpoma study.
3
Resistance to
macrolides is very common in staphylococci and
streptococci but prevalence varies from location to
location.
19
Varying rates of resistance to quinolones
(even same generation) by S. pneumoniae have been
reproted.
3
Therefore, the usual practice in some
health establishments where susceptibility test is
carried out on one quinolone and another is used for
treatment either due to cost constraints or
availability should be discontinued.
3
None of the antibiotics tested were effective
against all our isolates which makes antibiotic
susceptibility testing imperative for all strains of
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pneumococci isolated from the clinical setting before
treatment. The existence of multiple resistance poses
a greater threat for the management of diseases
caused by this bacterium.
17
Several strategies for example, simultaneous
multiple drug therapy, which have been helpful in
limiting the development of resistance in pathogens
such as HIV and Mycobacterium tuberculosis may not
be effective with S. pneumoniae because within-host
development of resistance during treatment is not
common in this bacterium.
1
Some successes have been recorded in reducing
resistance by judicious antibiotic use in the United
States and Europe.
1
This strategy may not be very
effective in a developing country like Nigeria where
antibiotics are sold without prescription over the
counter.
A newer strategy which seems to be very
promising is the use of the conjugate pneumococcal
vaccine which is reported to be very effective in
preventing both pneumococcal disease and carriage
of resistant serotypes included in the vaccine.
20
In conclusion, this study has shown that multiple
antibiotic resistant S. pneumoniae can be isolated
from the nasopharynx of some secondary school
students in Jos. In addition none of the antimicrobials
tested were effective against all isolates hence
antimicrobials susceptibility testing should be
conducted before treatment of diseases caused by S.
pneumoniae.
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